NASDAQ:SYNHSyneos Health Stock Price, Forecast & News

Syneos Health's stock was trading at $57.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SYNH shares have decreased by 1.6% and is now trading at $56.38. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Syneos Health.

Syneos Health is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Syneos Health.

Syneos Health will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Syneos Health Inc (NASDAQ:SYNH) issued its quarterly earnings data on Thursday, April, 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.64 by $0.04. The business earned $1.16 billion during the quarter, compared to the consensus estimate of $1.14 billion. Syneos Health had a return on equity of 10.33% and a net margin of 4.13%. The business's revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.59 earnings per share. View Syneos Health's earnings history.

Syneos Health issued an update on its second quarter earnings guidance on Wednesday, June, 3rd. The company provided earnings per share guidance of $0.48-0.52 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.47. The company issued revenue guidance of $1-1.02 billion, compared to the consensus revenue estimate of $979.53 million.

11 brokers have issued twelve-month price targets for Syneos Health's shares. Their forecasts range from $42.00 to $82.00. On average, they expect Syneos Health's stock price to reach $60.45 in the next year. This suggests a possible upside of 7.2% from the stock's current price. View analysts' price targets for Syneos Health.

News stories about SYNH stock have trended somewhat negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Syneos Health earned a coverage optimism score of -1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Syneos Health.

Some companies that are related to Syneos Health include EXACT Sciences (EXAS), PPD (PPD), Icon (ICLR), Charles River Laboratories Intl. (CRL), Exelixis (EXEL), PRA Health Sciences (PRAH), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Precigen (PGEN), STARPHARMA HOLD/S (SPHRY), Anavex Life Sciences (AVXL), Luna Innovations (LUNA), Pieris Pharmaceuticals (PIRS) and Auxly Cannabis Group (CBWTF). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include Alibaba Group (BABA), NVIDIA (NVDA), Netflix (NFLX), Square (SQ), AT&T (T), CVS Health (CVS), Gilead Sciences (GILD), UnitedHealth Group (UNH), Visa (V) and Delta Air Lines (DAL).

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Syneos Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.11%). Company insiders that own Syneos Health stock include Alistair Macdonald, H Lee Equity Fund Vi Thomas, Jason M Meggs, John M Dineen, Jonathan Olefson, Michelle Keefe, Paul Colvin and Robert Parks. View institutional ownership trends for Syneos Health.

SYNH stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. Company insiders that have bought Syneos Health stock in the last two years include Jason M Meggs, John M Dineen, Jonathan Olefson, and Paul Colvin. View insider buying and selling activity for Syneos Health.

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYNH stock can currently be purchased for approximately $56.38.

Syneos Health has a market capitalization of $5.87 billion and generates $4.68 billion in revenue each year. The company earns $131.26 million in net income (profit) each year or $2.83 on an earnings per share basis. Syneos Health employs 24,000 workers across the globe.

The official website for Syneos Health is www.syneoshealth.com.

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at 919-876-9300 or via email at [email protected]